# zoonotic diseases 

Zoonotic Diseases Table



| Disease name | Causative organisms | Agent/vector | Agent factors | Source of infection | Infectivity | Secondary attack rate | Vector control measures | Age of host | Type of immunity | Special Effects during pregnancy if any | Environmental factors | Transmission | Incubation period | Clinical features | Complications | Diagnosis(all methods) | Prevention |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Rabies | Lyssavirus type 1 (Rhabdoviridae family). | Dogs, cats, jackals, wolves, foxes, mongooses, monkeys, and bats. | Bullet-shaped neurotropic RNA virus; Street virus (natural) vs. Fixed virus (lab); presence of Negri bodies in CNS; sensitive to heat and disinfectants. | Saliva and CNS of rabid animals (dogs, cats, cows, pigs, etc.). | Infective 3 to 10 days before onset of symptoms and during the entire clinical course. | Not in source | Licensing, muzzling, and elimination of stray dogs; mass vaccination of 80% of dog population; observation of animals for 10 days. | All ages; children more prone due to higher exposure risk. | No natural immunity; active immunity via CCV/EEV/HDCV/PCECV/PVRV/PDEV; passive via RIG. | Pregnancy is not a contraindication to post-exposure prophylaxis. | Geographic barriers (water) act as isolation; observed in caves harboring bats. | Animal bites/scratches; licks on broken skin/mucosa; corneal or organ transplantation; rarely aerosol inhalation. | Commonly 2 to 8 weeks (range 4 days to >1 year). | Prodromal stage (fever, headache); Excitation stage (hydrophobia, aerophobia, spasms of pharynx, frothy saliva); stage of paralysis. | 100% fatality in clinical cases; post-vaccinal paralysis or encephalitis (rare). | Clinical (hydrophobia); Lab: Antigen detection (Fluorescent antibody, RREID/ELISA), Negri bodies in brain/neurons, virus isolation (mice inoculation), PCR. | Wound management (washing with soap/iodine); Post-exposure prophylaxis (ARV and RIG); Pre-exposure prophylaxis for high-risk groups. |
| Yellow fever | Flavivirus fibricus (Group B Arbovirus/Togavirus family). | Aedes aegypti (urban); Aedes africanus, A. simpsoni, Haemagogus species (sylvan). | Pantropic and neurotropic character; 17 to 28 millimicrons; Group B Togavirus. | Monkeys and forest rodents (jungle reservoir); Infected humans (urban). | Humans infective for mosquitoes 3 to 5 days after onset; mosquito infective for life after 8-12 days extrinsic incubation. | Not in source | Anti-larval and anti-adult measures; Aedes aegypti/Breteau index <1%; aircraft disinfection; airport perimeter (400m) control. | All ages; infants under 9 months usually not vaccinated unless in outbreak. | One attack gives lifelong immunity; 17D live attenuated vaccine (immunity lasts 10 years to life). | Vaccine safety not confirmed; avoid except in high-risk outbreaks. | Warm/moist climate (>24°C, >60% humidity); stagnant water in containers; banana plant axils. | Bite of infected female mosquito; Jungle cycle (monkey-mosquito), Intermediate, and Urban (man-mosquito) cycles; breastfeeding (rare). | 3 to 6 days. | Fever, headache, backache, black vomitus, jaundice, epistaxis, renal involvement (albuminuria). | Fatality rate 40 to 80% in malignant cases; hepatic and renal failure; shock; coma. | Clinical travel history; Serology (IgG/IgM ELISA, paired sera), virus isolation (blood inoculation), histopathology of liver. | 17D live attenuated vaccine; Vector control (source reduction); Port quarantine for 6 days; International Health Regulations. |
| Plague | Yersinia pestis. | Rat flea (Xenopsylla cheopis, X. astia, X. brasiliensis) and human flea (Pulex irritans). | Gram-negative bipolar coccobacillus; bacilli block proventriculus of flea ("blocked flea"); survives in burrows up to 11 months. | Infected rodents (R. rattus, Tatera indica), fleas, and humans with pneumonic plague. | Highly infectious; fleas remain infective for months; 'blocked' fleas are highly dangerous transmitters. | High in pneumonic outbreaks due to droplet spread. | Indoor residual spray (DDT/BHC/Malathion); insufflating rat burrows with 10% DDT; anti-rodent measures. | All ages affected; slightly higher in women due to house rat proximity. | No natural immunity; immunization (Sokhey’s modified Haffkine vaccine) provides temporary immunity (6 months). | Not in source | September to May season (Northern India); earthquakes (displacing rodents); grain godowns; damp rat burrows. | Bite of infected flea; droplet spread (pneumonic); direct contact with bubo pus or animal tissues; mechanical via proboscis. | Bubonic/Septicemic: 2 to 12 days (usually 3-7); Pneumonic: 1 to 3 days. | Bubonic: painful bubo (inguinal/femoral), sudden fever. Pneumonic: bloody sputum, cough. Septicemic: toxemia, prostration. | High fatality if untreated (~100% pneumonic); secondary pneumonia; meningitis; death. | Bipolar staining (Wayson/Giemsa); Culture (blood/CSF/bubo); Passive hemagglutination (PHA); Antigen-capture ELISA; Animal inoculation. | Notification; isolation; flea/rodent control; mass vaccination; chemoprophylaxis (Tetracycline/Doxycycline). |
| Leishmaniasis | Leishmania species (L. donovani, L. tropica, L. braziliensis). | Sandfly (Phlebotomus argentipes, P. papatasii). | Intracellular flagellate protozoan; Amastigote (LD bodies) in RE system; Promastigote in insect vector/culture. | Infected humans (Kala-azar in India); Dogs, jackals, and rodents ( Mediterranean/Zoonotic). | Patient infective as long as parasites persist in blood/skin; requires sandfly vector. | Not in source | Residual insecticide spray (DDT/Lindane/Pyrethroids) up to 6 feet; filling cracks in walls/floors; clearing vegetation. | All ages; VL peak in India is 5 to 9 years. | Recovery from VL/CL gives lasting immunity; Leishmanin (Montenegro) test monitors status. | Miltefosine is contraindicated in pregnancy; LAMB (Liposomal Amphotericin B) is safe. | Rural areas; damp, dark housing; proximity to cattle sheds/poultry; plains (<2000ft). | Bite of infected female sandfly; blood transfusion; contaminated syringes/needles; crushing the insect. | 1 to 4 months (range 10 days to 2 years). | Kala-azar: chronic irregular fever (double rise), splenomegaly, anemia, hyperpigmentation. CL: indolent sore/ulcer. | High mortality (up to 90% untreated); PKDL (Post-Kala-azar Dermal Leishmaniasis); HIV co-infection. | Demonstration of LD bodies (bone marrow/spleen/lymph node biopsy); rk39 dipstick/RDT; Aldehyde test; ELISA; DAT. | Early case detection/treatment (MDT); fine-mesh mosquito nets; repellents; sandfly control (DDT); health education. |
| Nipah virus | Nipah virus (Henipavirus). | Fruit bats (Pteropus genus) and pigs. | RNA virus (Paramyxoviridae family); CDC Category C Bioterrorism Agent. | Infected fruit bats, pigs, and humans. | High; present in bodily fluids and respiratory secretions. | High in hospital/family (person-to-person) settings. | Reducing exposure to bats and sick pigs; avoidance of raw date palm sap. | All ages. | Not in source | Not in source | Presence of fruit trees attracting bats; consumption of contaminated date palm sap; bioterrorism threat. | Direct contact with infected animals; consumption of contaminated date palm sap; human-to-human (droplets/fomites). | 4 to 14 days. | Fever, headache, drowsiness, myalgia, respiratory distress, dizziness, fatal encephalitis, coma. | Acute respiratory failure; coma; seizure disorder; neurological sequelae; death. | Real-time RT-PCR (bodily fluids); ELISA (antibody detection); Virus isolation (cell culture). | Avoid raw date palm sap; use PPE for patient care; strict isolation; no vaccine available. |
| Brucellosis | Brucella species (B. melitensis, B. abortus, B. suis, B. canis). | Cattle, goats, sheep, pigs, dogs, horses, buffaloes, camels. | Gram-negative, non-motile coccobacilli; sensitive to heat; survives in milk and meat. | Uterine discharges, placenta, urine, milk, and meat of infected animals. | High through raw milk/aerosols; no evidence of man-to-man infection. | Not in source | Raising brucella-free herds; test and slaughter; animal vaccination (Strain 19). | Susceptibility higher in 15 to 45 years age group (occupational). | Immunity follows infection; human live vaccine (19-BA) available in some regions. | Risk of spontaneous abortion in animals. | Occupational exposure for farm workers/vets; unhygienic milk production; animal habitations. | Ingestion of raw milk/meat; contact with animal discharges/placenta; airborne (labs/slaughterhouses). | 5 to 30 days (usually 2 to 3 weeks; range up to 6 months). | Undulant fever (bouts of 1-2 weeks), profuse sweating (early morning), arthralgia, hepatosplenomegaly. | High relapse rate; endocarditis; osteomyelitis; meningitis; orchitis. | Blood/Bone marrow culture (up to 6 weeks); Agglutination reaction (SAT); Brucella IgG ELISA; Intradermal test. | Pasteurization of milk; vocational training; protective gear (gloves); animal vaccination. |
| Leptospirosis | Leptospira interrogans (several serovars). | Rodents (rats, mice), cattle, pigs, dogs. | Thin, motile spirochetes; sensitive to HCl, chlorine, and heat; lives months in water/damp soil. | Urine of infected animals (especially rodents). | Organisms remain viable in moist environments; excreted in urine for lifetime of rodents. | Not in source | Rodent control (Zinc phosphide); disinfection of workplace. | Commonly 20 to 45 years (occupational risk); all ages susceptible. | Solid serovar-specific immunity; vaccine available for high-risk farmers and pets. | Can cause fetal death or abortion. | Heavy rainfall/flooding; soil salinity; alkaline pH; damp soil/mines/sewers. | Direct skin contact (abrasions) or mucous entry with contaminated urine/water/soil; inhalation of droplets. | Usually 10 days (range 4 to 20 days). | Fever, chills, myalgia (calf tenderness), conjunctival suffusion, jaundice (Weil's disease), albuminuria. | Acute renal failure; pulmonary hemorrhagic syndrome; circulatory collapse; death (10%). | Dark-field microscopy; Isolation (blood 1st week, urine after); Serology (IgM ELISA, MAT - Gold Standard); PCR. | Rodent control; protective footwear/clothing; drainage of wet areas; prophylaxis (Doxycycline). |
| Salmonellosis | Salmonella species (S. typhimurium, S. enteritidis, S. cholerae-suis). | Animals (cattle, poultry, rodents, swine) and houseflies (mechanical vector). | Gram-negative bacilli; enterotoxin producer; sensitive to heat (>70°C); multidrug resistant strains. | Infected animals; eggs/poultry; human patients and temporary carriers. | Communicable during period of excretion (days to weeks); highly infectious via feco-oral route. | Not in source | Fly control; environmental sanitation (garbage/refuse control). | All ages; common in children (food poisoning) and elderly. | Temporary; specific to strain; active immunization (TAB vaccine/Typhim Vi) for typhoid types. | Not in source | Unsanitary kitchens; room temperature storage; poor food hygiene. | Ingestion of contaminated food (meat, milk, eggs); fecal-oral; rat droppings; waterborne. | 12 to 24 hours (up to 5 days). | Salmonella enterocolitis: nausea, headache, vomiting, diarrhea, fever. Septicemia with focal lesions. | Dehydration; septicemia; focal infections (osteomyelitis, meningitis); death. | Culture of feces/vomit/suspected food; Phage typing; Serological tests (antibody titer). | Thorough cooking of meat/eggs; refrigeration; hand washing; food handler screening; pasteurization. |
| Scrub typhus | Orientia tsutsugamushi (formerly Rickettsia tsutsugamushi). | Trombiculid mite (chigger: Leptotrombidium deliense/akamushi). | Rickettsial organism; maintained by transovarial passage in mites. | Infected mite larvae (chiggers); wild rodents. | Not directly person to person; larvae are the only parasitic stage. | Not in source | Insecticide application to ground/vegetation (lindane/chlordane); clearing shrubs. | All ages; common in adult workers/campers in jungle or scrubby areas. | No vaccine available. | Not in source | Scrubby terrain, forests, secondary vegetation; grass and herbage. | Bite of infected six-legged mite larva (chigger). | 5 to 14 days (usually 10 to 12 days). | Eschar (punched-out ulcer with blackened scab), sudden fever, headache, maculopapular rash (5th day), lymphadenopathy. | Fatality rate 1 to 30%; pneumonitis; meningoencephalitis; multi-organ involvement. | Clinical (eschar); Lab: Weil-Felix reaction (OXK), IFA, ELISA, PCR, mice inoculation. | Repellents (DEET/DBP) on skin/clothes; protective clothing; chemoprophylaxis (Tetracycline/Chloramphenicol). |
| Murine fever | Rickettsia typhi (Rickettsia mooseri). | Rat flea (Xenopsylla cheopis). | Rickettsial organism; infection in rats is inapparent and non-fatal. | Infected rats (R. rattus, R. norvegicus), mice, squirrels. | Communicable via flea throughout its life; no direct man-to-man transmission. | Not in source | Insecticides for rat runs/burrows; flea control (DDT/Malathion); rodent control. | All ages; higher incidence in males. | Lasting immunity after attack; no vaccine available. | Not in source | Grain stores; urban areas/docks with high rat density; poor sanitation. | Bite of infected rat flea; inoculation of flea feces into skin abrasions; inhalation of dried feces. | 1 to 2 weeks (commonly 12 days). | Fever (7-14 days), headache, flushed face, maculopapular rash on 4th/5th day. | Rarely fatal (<1%); pneumonia. | Weil-Felix reaction (OX-19 positive in 2nd week); Complement fixation; ELISA; IFA. | Rodent control; flea control; environmental sanitation; rodent-proofing of buildings. |
| Q fever | Coxiella burnetii. | Ticks (reservoir in animals); no vector required for human transmission (aerosol). | Rickettsial organism; highly resistant spore-like stage; survives pasteurization. | Infected livestock (cattle, sheep, goats) and wild animals. | Highly infectious via inhalation of dust/aerosols (low dose required). | Not in source | Tick control (DDT/Acaricides) in animals. | All ages; predominantly adults (occupational risk). | Lasting immunity after infection; inactivated vaccine available for high-risk groups. | Not in source | Arid regions; livestock farms; slaughterhouses; dusty environments. | Inhalation of contaminated dust; consumption of raw milk; contact with animal products (placenta); tick bites (rare). | 2 to 3 weeks. | Acute onset fever, chills, severe headache, malaise, atypical pneumonia; notably no rash. | Chronic endocarditis; hepatitis; encephalitis. | Serology (Complement fixation, IFA, ELISA); PCR; isolation of agent. | Pasteurization of milk; sanitary cattle sheds; hygiene during calving; disinfection of products. |
| Taeniasis | Taenia saginata (Beef), Taenia solium (Pork), Taenia asiatica. | Cattle and Pigs. | Flat ribbon-like cestodes; eggs viable in soil for months; requires two vertebrate hosts. | Infected beef ('cysticercus bovis') or pork ('cysticercus cellulosae'). | Carrier state in man lasts years; T. solium eggs are infective to humans (causing cysticercosis). | Not in source | Meat inspection; sanitary disposal of human excreta; pig housing control. | All ages; T. solium rare in certain religious groups. | No permanent immunity; second infections possible. | Not in source | Open defecation; use of raw sewage for fertilizing grazing lands. | Ingestion of undercooked infected meat; T. solium also via ingestion of eggs (cysticercosis) in food/water. | 8 to 14 weeks (until adult tapeworm/eggs appear). | Intestinal: abdominal discomfort, chronic indigestion, passage of segments. Somatic (T. solium): epilepsy, intracranial pressure. | Neurocysticercosis (seizures, death); intestinal obstruction; appendicitis. | Stool microscopy (eggs/proglottids); Imaging (CT/MRI) for cysticercosis; Eosinophilia; ELISA. | Avoiding raw/undercooked meat; meat inspection; sanitary latrines; Albendazole/Praziquantel treatment. |
| Hydatid disease | Echinococcus granulosus (unilocular), E. multilocularis (alveolar). | Dog (definitive host); Sheep, cattle, and humans (intermediate hosts). | Small tapeworm (4-7mm); larvae form slow-growing multilocular cysts; eggs resistant in soil. | Vegetables/food contaminated with dog feces; handling infected dogs. | Cysts grow slowly in tissues; not directly transmissible person-to-person. | Not in source | Deworming pet dogs; stray dog control; preventing dogs from eating raw offal. | All ages; infection often acquired in childhood. | No natural immunity. | Not in source | Sheep-raising communities; uncontrolled slaughter; close contact with dogs. | Fecal-oral (ingestion of eggs from dog feces); accidental host (man); inhalation of contaminated dust. | Varies (months to years). | Slow-growing cystic tumors (liver 70%, lungs, brain); pressure symptoms (jaundice); allergic reactions. | Cyst rupture causing fatal anaphylaxis or implantation/metastatic cysts; organ dysfunction. | Imaging (USG, CT, MRI, X-ray); Serology (ELISA, Casoni’s intradermal skin test). | Personal hygiene (hand washing); washing vegetables; treating pet dogs; deep burial of infected offal. |